Stockreport

Psyence Biomedical to not proceed with Clairvoyant acquisition [Seeking Alpha]

Psyence Biomedical Ltd. - Ordinary Shares  (PBM) 
PDF PBM after hours to $0.103. Earlier in September, Psyence Biomedical said it has entered into a term sheet with privately held Clairvoyant Therapeutics to acquire 100% [Read more]